Chaput de Saintonge D M, Levine D F, Savage I T, Burgess G W, Sharp J, Mayhew S R, Sadler M G, Moody R, Griffiths R, Griffiths S, Meadows G
Br Med J (Clin Res Ed). 1982 Apr 10;284(6322):1078-81. doi: 10.1136/bmj.284.6322.1078.
A randomised double-blind controlled trial compared three-day and 10-day courses of amoxycillin (25 mg/kg daily) in children with otitis media. Seventeen doctors from five centres admitted 84 children between the ages of 2 and 10 years. Symptoms and signs were measured on admission to the trial, on day 3, and on day 15. Mother's observations were recorded daily for 10 days. Audiograms were performed at four and 12 weeks after the end of the trial. The treatment groups showed little difference in the speed of resolution of symptoms and signs, the numbers of primary treatment failures, or the frequency of recurrent ear infections. There were no complications in either group. Most children with otitis media can probably be successfully and safely treated with no more than a three-day course of amoxycillin providing their progress is reviewed about the fifth or sixth day after treatment started. This policy could save over 1 million pounds annually in antibiotic costs.
一项随机双盲对照试验比较了阿莫西林(每日25毫克/千克)三日疗程和十日疗程对患有中耳炎的儿童的治疗效果。来自五个中心的17名医生收治了84名年龄在2至10岁之间的儿童。在试验入组时、第3天和第15天对症状和体征进行了测量。母亲们连续10天每天记录观察结果。在试验结束后的第4周和第12周进行听力图检查。治疗组在症状和体征的缓解速度、初次治疗失败的数量或耳部感染复发的频率方面几乎没有差异。两组均无并发症。大多数中耳炎患儿在治疗开始后的第五或第六天进行病情复查的情况下,使用不超过三日疗程的阿莫西林可能就能成功且安全地得到治疗。这一政策每年可节省超过100万英镑的抗生素费用。